Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 19

Showing 19 citing articles:

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe
Lorenza Rimassa, Ángela Lamarca, Grainne M. O’Kane, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101170-101170
Open Access | Times Cited: 2
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
I. A. Mavroeidi, Jonathan Burghofer, Stavros Kalbourtzis, et al.
ESMO Open (2024) Vol. 9, Iss. 8, pp. 103630-103630
Open Access | Times Cited: 5
Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine
Jibran Ahmed, Carlos Torrado, Anca Chelariu, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 4
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Genomische Instabilität als Rationale bei der Krebstherapie
Anna Fichtl, Thomas Jens Ettrich, Lukas Perkhofer
Forum (2025)
Closed Access
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics
Andréa Witz, Julie Dardare, Margaux Betz, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Precision oncology in biliary tract cancer: the emerging role of liquid biopsy
Marco de Scordilli, M. Bortolot, Sara Torresan, et al.
ESMO Open (2025) Vol. 10, Iss. 5, pp. 105079-105079
Open Access
Molecular signatures of intrahepatic Cholangiocarcinoma: Role in targeted therapy selection
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures
Francesco Vasuri, E Albertini, Lucía Miranda, et al.
Pathologica (2025) Vol. 117, Iss. 1, pp. 10-17
Open Access
Advancing Precision Medicine: The Role of Genetic Testing and Sequencing Technologies in Identifying Biological Markers for Rare Cancers
Joviana Farhat, Lara Alzyoud, Mohammad Alwahsh, et al.
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Genomic landscape of biliary tract cancer and corresponding targeted treatment strategies
Daisaku Yamada, Shogo Kobayashi, Yuichiro Doki, et al.
International Journal of Clinical Oncology (2025)
Open Access
Molecular and Pathological Heterogeneity of Synchronous Small and Large Duct Intrahepatic Cholangiocarcinoma—A Case Series
S Popovska, Vladislav Nankov, Boryana N. Ilcheva, et al.
Current Oncology (2025) Vol. 32, Iss. 5, pp. 255-255
Open Access
RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
Jiang Chang, Yaodong Zhang, Tao Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma
Timothy J. Kendall, Diletta Overi, Maria Guido, et al.
JHEP Reports (2024) Vol. 6, Iss. 6, pp. 101067-101067
Open Access | Times Cited: 2
Liver transplantation for tumor entities
Damiano Patrono, Nicola De Stefano, Renato Romagnoli
Current Opinion in Organ Transplantation (2024) Vol. 29, Iss. 4, pp. 255-265
Closed Access | Times Cited: 2
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
Tarık Demir, Carolyn Moloney, Devalingam Mahalingam
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104388-104388
Closed Access | Times Cited: 1
Improving gastrointestinal cancer therapy by uniting stakeholders
Michael Quante, Anna Saborowski, C. Benedikt Westphalen
ESMO Gastrointestinal Oncology (2024) Vol. 3, pp. 100040-100040
Open Access
Which therapy in biliary tract cancer? Review of main concerns in diagnosis and choice of therapy in advanced setting, current standard, and new options
Ester Oneda, Serena Astore, Laura Gandolfi, et al.
Expert Opinion on Pharmacotherapy (2024)
Open Access
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
Joy Awosika, Cecilia Monge, Tim F. Greten
Hepatic Oncology (2024) Vol. 11, Iss. 1
Open Access
Page 1

Scroll to top